Press release
Genomic Biomarker Market Thrives with Advances in Predictive Diagnostics and Targeted Therapies | Roche, Thermo Fisher, Illumi
Genomic Biomarker Market OverviewThe Genomic Biomarker Market is estimated to increase from USD 7.8 Billion in 2025 to USD 16.4 Billion by 2032, reflecting a CAGR of 11.1% during the forecast period.
The latest report (2025-2032) on the Genomic Biomarker Market by Coherent Market Insights offers an in-depth analysis of market trends, growth factors, challenges, and competition. It explores market size, revenue, production, consumption, and CAGR, using reliable research methods for accuracy. The report also covers technological advancements, pricing trends, consumer behavior, and investment opportunities, helping businesses make smart decisions and stay competitive. With a focus on Market growth and future opportunities, this report is a valuable resource for industry professionals, investors, and stakeholders. The Genomic Biomarker Market has grown rapidly due to rising demand, a growing customer base, and new technologies. This report provides a clear view of competition and future prospects, offering data-driven strategies for success.
π‘Request a Sample of the US Tariff Impact Analysis Report Today: - https://www.coherentmarketinsights.com/insight/request-sample/4578
π Scope and Insights of the Genomic Biomarker Market
The Genomic Biomarker Market Report provides a comprehensive analysis of industry trends, growth drivers, and challenges. It offers detailed market segmentation based on product type, application, and geography, along with insights into consumer behavior and preferences shaping market dynamics. The report examines key players, their competitive strategies, and emerging opportunities, helping businesses identify growth prospects. It includes data-driven forecasts on market size and future potential, supported by quantitative analysis. Additionally, it explores regulatory factors and technological advancements impacting the industry, making it an essential resource for stakeholders seeking strategic decision-making insights.
π Following are the Players Analyzed in the Report:
β Thermo Fisher Scientific
β F. Hoffmann-La Roche AG
β Liquid Genomics Inc.
β AROS Applied Biotechnology A/S
β Myriad Genetics Inc.
β QIAGEN
β Eurofins Scientific
β Genomic Health
β Bio-Rad Laboratories Inc.
β Epigenomics AG
β Aepodia
β© Comprehensive Segmentation and Classification of the Report:
By Indication: Oncology, Cardiovascular diseases, Neurological diseases, Others
By End User: Hospitals, Diagnostic & Research Laboratories, Others
π β Make Smarter Decisions - Buy the US Tariff Impact Analysis Report : https://www.coherentmarketinsights.com/insight/buy-now/4578
π Geographical Landscape of the Genomic Biomarker market:
The Genomic Biomarker Market report offers detailed insights into the market landscape, which is further categorized into sub-regions and specific countries. This section of the report not only highlights the market share for each country and sub-region but also identifies potential profit opportunities within these areas.
β North America (U.S., Canada, Mexico)
β Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
β Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
β South America (Brazil, Argentina, Rest of SA)
β Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
π Key Benefits for Stakeholders
β¦ Quantitative analysis of market segments, trends, estimations, and dynamics (2025-2032).
β¦ Insights into key drivers, restraints, and opportunities.
β¦ Porter's Five Forces analysis for strategic decision-making.
β¦ Segmentation analysis to identify market opportunities.
β¦ Revenue mapping of major countries by region.
β¦ Benchmarking and positioning of market players.
β¦ Analysis of regional and global trends, key players, and growth strategies.
β© Reasons to Purchase the Report
π Strategic Competitor Insights: Gain critical information and analysis on key competitors to develop effective sales and marketing strategies.
π Identify Emerging Players: Discover new entrants with promising product portfolios and formulate counter-strategies to enhance your competitive edge.
π Target Client Identification: Classify potential new clients or partners within your target demographic for better market penetration.
π Tactical Initiative Development: Understand the focal areas of leading companies to craft informed tactical initiatives.
π Mergers and Acquisitions Planning: Make strategic decisions regarding mergers and acquisitions by pinpointing top manufacturers in the market.
π Licensing Strategy Development: Identify prospective partners with attractive projects to create robust in-licensing and out-licensing strategies, thereby enhancing business potential.
π Support for Presentations: Utilize reliable, high-quality data and analysis to strengthen your internal and external presentations.
This report provides actionable growth insights through a comprehensive analysis that includes secondary research, primary interviews with industry stakeholders and competitors, as well as validation and triangulation using the Coherent Market Insights regional database. Experts have meticulously compiled primary data from market participants across the value chain in all regions, along with insights from industry specialists, to deliver both qualitative and quantitative findings.
π Table of Content: Genomic Biomarker Market Scenario 2025
1 Report Overview
1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social, and Technological) Analysis of Genomic Biomarker Market
2 Market Trends and Competitive Landscape
3 Segmentation of Genomic Biomarker Market by Types
4 Segmentation of Genomic Biomarker Market by End-Users
5 Market Analysis by Major Regions
6 Product Commodity of Genomic Biomarker Market in Major Countries
7 North America Genomic Biomarker Landscape Analysis
8 Europe Genomic Biomarker Landscape Analysis
9 Asia Pacific Genomic Biomarker Landscape Analysis
10 Latin America, Middle East & Africa Genomic Biomarker Landscape Analysis
11 Major Players Profile
π β Make Smarter Decisions - Buy the US Tariff Impact Analysis Report : https://www.coherentmarketinsights.com/insight/buy-now/4578
π¬ FAQ's
Q.1 What are the main factors influencing the Genomic Biomarker Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market's opportunities, risks, and general structure?
Q.4 Which of the top Genomic Biomarker Market companies compare in terms of sales, revenue, and prices?
Q.5 How are market types and applications and deals, revenue, and value explored?
Q.6 What does a business area's assessment of agreements, income, and value implicate?
βοΈ PR Authored By:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of Market Insights.
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
βοΈ Contact Us:
Mr. Shah
Senior Client Partner - Business Development
Coherent Market Insights
Phone:
πUS: +1-206-701-6702
πUK: +44-020-8133-4027
πAUS: +61-2-4786-0457
πIndia: +91-848-285-0837
βEmail: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Genomic Biomarker Market Thrives with Advances in Predictive Diagnostics and Targeted Therapies | Roche, Thermo Fisher, Illumi here
News-ID: 3999878 • Views: β¦
More Releases from Coherent Market Insights

Pharmacy Automation Market Booming with Smart Dispensing Technology and Medicati β¦
Global Pharmacy Automation Market size is projected to reach US$ 11.97 Bn by 2032 from an estimated US$ 6.85 Bn in 2025, exhibiting a CAGR of 8.3%.
Coherent Market Insights announces the release of its latest report Pharmacy Automation Market" Share and Ranking, Overall Sales, Growth and Demand Forecast 2025-2032". Based on historical analysis and forecast calculations, this report provides a comprehensive analysis of the Pharmacy Automation Market, including market size,β¦

Fundus Camera Market Set to Witness Significant Growth by 2025-2032 | Carl Zeiss β¦
Coherent Market Insights announces the release of its latest report Fundus Camera Market" Share and Ranking, Overall Sales, Growth and Demand Forecast 2025-2032". Based on historical analysis and forecast calculations, this report provides a comprehensive analysis of the Fundus Camera Market, including market size, share, demand, industry development status, and forecasts. Provides advanced statistics and information on the Industry conditions and studies the strategic patterns adopted by prominent players acrossβ¦

Prefilled Syringes Market Growing with Biologics Delivery Needs and Focus on Saf β¦
Prefilled Syringes Market is estimated to be valued at USD 7.18 Bn in 2025 and is expected to reach USD 10.51 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.
Coherent Market Insights announces the release of its latest report Next Generation Sequencing Market" Share and Ranking, Overall Sales, Growth and Demand Forecast 2025-2032". Based on historical analysis and forecast calculations, this report providesβ¦

Next Generation Sequencing Market Soaring with Genomic Research Acceleration and β¦
The next generation sequencing market is estimated to be valued at USD 18.94 Bn in 2025 and is expected to reach USD 49.49 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 14.7% from 2025 to 2032.
Coherent Market Insights announces the release of its latest report Next Generation Sequencing Market" Share and Ranking, Overall Sales, Growth and Demand Forecast 2025-2032". Based on historical analysis and forecast calculations, thisβ¦
More Releases for Genomic
Emerging Trends Influencing The Growth Of The Genomic Biomarker Market: Technolo β¦
The Genomic Biomarker Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Genomic Biomarker Market Size Expected to Be by 2034?
The size of the genomic biomarker market has witnessed swift expansion in the recent past. It is slated to expand from aβ¦
Growth Of Genomic Biomarkers Market Driven By Personalized Medicine Demand: A Si β¦
The Genomic Biomarkers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Genomic Biomarkers Market Size and Projected Growth Rate?
The genomic biomarkers market size has experienced rapid growth in recent years. It will grow from $7.42 billion in 2024 to $8.72 billion inβ¦
Impact of Chronic Disease Prevalence on Genomic Biomarker Market SizeGrowth Driv β¦
How Are the key drivers contributing to the expansion of the genomic biomarker market?
The escalating presence of enduring illnesses is projected to fuel the expansion of the genomic biomarker Market Sizein the future. These chronic diseases are long-term health concerns that persistently retain over periods, often signifying gradual progression. The heightened presence of such chronic diseases is linked to aging populations and incrementing instances of lifestyle-related complications such as obesityβ¦
Top Factor Driving Genomic Biomarker Market Growth in 2025: Impact of Chronic Di β¦
How Big Is the Genomic Biomarker Market Expected to Be, and What Will Its Growth Rate Be?
The size of the genomic biomarker market has seen a swift expansion in recent times. It's expected to increase from $8.4 billion in 2024 to $9.9 billion in 2025, growing at a compound annual growth rate (CAGR) of 18.0%. The historic period growth can be credited to the growing awareness about genetic disorders, heightenedβ¦
Genomic Biomarker Market Future Business Opportunities 2025-2032 | Liquid Genomi β¦
Latest Report, titled "Genomic Biomarker Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Genomic Biomarker market has been expanding significantlyβ¦
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to theβ¦